TICKERNERD
Menu
CBTCBTBasic Materials · Specialty Chemicals

CBT Stock Forecast: Cabot Corp. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$80
+1.13% on the day

The 6 Wall Street analysts covering Cabot Corp. hold a median 12-month price target of $91 — +14.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 87 of 100 as at 10 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$4.1B
Ticker Nerd rank
87 / 100
Median analyst target
$91
Analysts covering
6
Revenue$982.0M+6.4% y/y
Operating income$98.0M
Net income$14.0M
Free cash flow$37.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−1.9%
1M
−7.9%
YTD
+22.3%
1Y
+0.2%
From 52W high
−14.2%
From 52W low
+39.0%
$57
$93
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CBT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Cabot Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 10 Sept 2026
87 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
96
Quality
90
Revisions
81
Volatility
75
Issuance
68
Accruals
68
Momentum
65
Size
26
Growth
23

Value (96): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Growth (23): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CBT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CBT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$50$60$70$80$90$100Oct 25Jan 26Apr 26Jul 26CBTHigh $100Median $91Low $78

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says6 analysts
2 Buy3 Hold1 Sell
Low $78Median $91High $100

The green dot is the last close — the median target sits +14.2% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 2 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
7 Aug 2026JP MorganMaintainsUnderweight$70 → $78
5 Aug 2026UBSMaintainsNeutral$97 → $92
25 June 2026MizuhoMaintainsNeutral$80 → $90
25 June 2026MizuhoMaintainsNeutral—
8 June 2026Truist SecuritiesInitiatesBuy—
13 May 2026JP MorganMaintainsUnderweight—
8 May 2026UBSMaintainsNeutral—
6 May 2026MizuhoMaintainsNeutral—
5 Feb 2026MizuhoDowngradeNeutral—
5 Feb 2026UBSMaintainsNeutral—
12 Jan 2026UBSMaintainsNeutral—
18 Dec 2025MizuhoMaintainsOutperform—
28 Nov 2025JP MorganMaintainsUnderweight—
17 Nov 2025MizuhoMaintainsOutperform—
5 Nov 2025UBSMaintainsNeutral—
3 Oct 2025MizuhoMaintainsOutperform—
5 Aug 2025UBSMaintainsNeutral—
7 Apr 2025UBSMaintainsNeutral—
21 Feb 2025JP MorganMaintainsUnderweight—
7 Jan 2025MizuhoMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CBT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

CBT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Cabot Corp. returned +0.2% against +17.5% for the S&P 500, dividends included.

CBT vs S&P 500, last 12 monthsTotal return, rebased to 100
708090100110120Oct 25Jan 26Apr 26Jul 26CBTS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CBT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.6%
Analysts raising
3
Analysts cutting
2
Fundamentals

Cabot Corp. (CBT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
22.5×

Cheaper than 34% of US stocks

Price / sales
1.1×

Cheaper than 67% of US stocks

Price / book
2.6×

Cheaper than 38% of US stocks

EV / EBITDA
7.2×

Cheaper than 48% of US stocks

Growth & margins
Revenue growth (YoY)
6.4%

Higher than 42% of US stocks

Earnings growth (YoY)
−94.1%

Higher than 3% of US stocks

Gross margin
18.7%

Higher than 19% of US stocks

Operating margin
14.3%

Higher than 71% of US stocks

Net margin
5.2%

Higher than 60% of US stocks

Returns & dividend
Return on equity
13.3%

Higher than 71% of US stocks

Return on assets
8.9%

Higher than 90% of US stocks

Dividend yield
2.4%

Higher than 52% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Cabot Corp. (CBT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Cabot Corp. has a market value of $4.1B and an enterprise value of $5.3B.

  • Revenue in the twelve months to 30 June 2026: $3.6B. The latest quarter grew 6.4% year on year.

  • Net income over the same four quarters: $228.0M, a 6.3% net margin.

  • Diluted earnings per share, trailing twelve months: $3.55.

  • Free cash flow in the twelve months to 30 June 2026: $281.0M.

  • Cabot Corp. spent $140.0M on share buybacks and $97.0M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 51.6M.

  • Trailing P/E: 22.5×; forward P/E: 11.4× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 2.38%, paying out 51% of earnings.

  • Cabot Corp. employs 4,064 people — $894K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 10 Sept 2026

Data provided by Twelve Data

Peers

CBT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
CBTCabot Corp.$4.1B
87
AVNTAvient Corp.$3.8B
95
CLMTCalumet, Inc.$4.9B
80
PRMPerimeter Solutions, Inc.$5.0B
22
ASHAshland, Inc.$3.2B
87
BCPCBalchem Corp.$5.4B
93
SXTSensient Technologies Corp.$5.6B
64

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Cabot Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CBT news & analysis

Cabot Stock Rallies 17% in 6 Months: Here's What's Driving the Upside

Zacks Investment Research · 9 Sept 2026positive

Cabot Corp (CBT) shares have risen approximately 16.8% over the past six months, with the uptick attributed to demand for battery materials, capacity expansion, and cost savings that are supporting growth and cash generation.

Why it matters — A Cabot stock watcher would care because the share price gain reflects operational strengths in battery materials and efficiency initiatives that underpin the company's growth and cash generation.

Why Is Cabot (CBT) Down 1.6% Since Last Earnings Report?

Zacks Investment Research · 2 Sept 2026neutral

Cabot reported earnings 30 days ago, and its stock has declined 1.6% since that report. The article examines what might be next for the company's stock.

Why it matters — A CBT watcher would want to understand the post-earnings stock movement and what factors may influence the company's near-term performance.

Reasons Why You Should Retain Cabot Stock in Your Portfolio Now

Zacks Investment Research · 2 Sept 2026positive

Zacks notes that Cabot Corp. is benefiting from battery-materials growth, circular products, and capacity expansion, while weaker pricing and rising costs continue to pressure profitability. The article frames these factors as reasons to retain the stock in a portfolio.

Why it matters — A Cabot watcher would care because the report highlights the balance between the company's growth drivers and the cost and pricing headwinds affecting its earnings.

Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029

GlobeNewsWire · 12 Aug 2026neutral

Cabot Corporation announced it priced a public offering of $350 million of 4.950% senior unsecured notes due 2029. The notes are being sold to the public at 99.993% of their face amount.

Why it matters — The offering adds to Cabot's debt and capital structure, which is relevant to watchers tracking the company's financing and balance sheet.

CBT Q3 Earnings Beat Estimates on Performance Chemicals Strength

Zacks Investment Research · 10 Aug 2026positive

Cabot Corp.'s Q3 fiscal 2026 earnings beat estimates, with strength in its Performance Chemicals segment offsetting margin pressure in Reinforcement Materials.

Why it matters — The earnings beat, driven by Performance Chemicals, signals resilience for Cabot despite ongoing margin challenges in its Reinforcement Materials business.

FAQ

Frequently asked questions about CBT stock

What is the CBT stock price forecast for 2026-2027?

The 6 Wall Street analysts covering Cabot Corp. have a median 12-month price target of $91, with estimates ranging from $78 to $100. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CBT stock a buy right now?

Of the 6 analysts covering Cabot Corp., 2 rate it a Buy, 3 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Cabot Corp. 87 out of 100 across roughly 4,600 US stocks as at 10 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CBT?

As at 10 Sept 2026, Cabot Corp. ranks 87 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (96 of 100).

Will CBT stock go up?

No one can know that. What the data says: the median 12-month target from 6 analysts implies +14.2% from the last close, and Ticker Nerd's factor model ranks Cabot Corp. 87 out of 100 as at 10 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CBT stock forecast for 2030?

No analyst covering Cabot Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CBT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $78 to $100 over the next 12 months.

How has CBT stock performed over the past year?

Cabot Corp. returned +0.2% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Cabot Corp. do?

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Cabot Corporation develops and supplies a broad portfolio of advanced materials used in transportation, infrastructure, environment, consumer, electronics, and industrial applications.

What is the latest news on CBT?

The most recent item we track (Zacks Investment Research, 9 Sept 2026): "Cabot Stock Rallies 17% in 6 Months: Here's What's Driving the Upside". Cabot Corp (CBT) shares have risen approximately 16.8% over the past six months, with the uptick attributed to demand for battery materials, capacity expansion, and cost savings that are supporting growth and cash generation.

Company

About Cabot Corp.

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Cabot Corporation develops and supplies a broad portfolio of advanced materials used in transportation, infrastructure, environment, consumer, electronics, and industrial applications. Its core offerings include reinforcing carbons, engineered elastomer composites, specialty carbons, conductive additives, battery materials, fumed metal oxides, masterbatches, conductive compounds, inkjet colorants, and aerogel. The company serves customers that rely on high-performance materials to improve durability, conductivity, reinforcement, dispersion, and insulation in finished products and manufacturing processes. Cabot Corporation operates through the Reinforcement Materials and Performance Chemicals segments, giving it exposure to both large-volume industrial markets and more specialized performance applications. With a focus on materials science and formulation expertise, Cabot Corporation plays an important role in supplying components that enhance product performance across multiple end markets.

CEO Mr. Sean D. Keohane · 4,064 employees · United States · https://www.cabotcorp.com